Immune Signatures Dominate Molecular Subtyping to Predict Response to Neoadjuvant Immunotherapy
Joshua J. Meeks, A. Gordon Robertson
Topics & Concepts
MedicineSubtypingImmunotherapyImmune systemNeoadjuvant therapyImmunologyInternal medicineCancerComputer scienceProgramming languageBreast cancerImmunotherapy and Immune ResponsesBladder and Urothelial Cancer TreatmentsCancer Immunotherapy and Biomarkers